HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Musculoskeletal11 papers

Myxopapillary ependymoma

Last edited: 4/15/2026

Overview

Myxopapillary ependymoma is a rare, slow-growing neoplasm typically arising from the filum terminale of the spinal cord, predominantly affecting young adults 1. It often presents with radicular pain, backache, and neurological deficits due to spinal cord compression 1.

Diagnosis

  • Clinical Presentation: Radicular pain, backache, and progressive neurological deficits 1.
  • Imaging: MRI is essential for diagnosis, showing characteristic features such as a well-defined, enhancing mass near the conus medullaris 1.
  • Biopsy and Pathology: Histopathological examination confirms the diagnosis with characteristic myxoid matrix and papillary structures 1.
  • Grading: Typically classified as WHO Grade I, though rare higher-grade variants exist 1.

    • Management

  • Surgical Resection: Primary treatment, aiming for complete resection to minimize recurrence 1.
  • Radiation Therapy: Considered for incomplete resection or high-risk features, though evidence is limited 1.
  • Adjuvant Therapy: No standard adjuvant chemotherapy; treatment decisions are individualized based on extent of resection and patient factors 1.

    • Special Populations

  • Pediatrics: Limited data; management principles similar to adults but with closer monitoring due to developmental considerations 1.
  • Elderly: Surgical risks must be carefully weighed against benefits; multidisciplinary team input is crucial 1.
  • Comorbidities: Presence of comorbidities may influence surgical approach and postoperative management strategies 1.

    • Key Recommendations

  • Primary Treatment with Surgical Resection: Aim for complete resection to reduce recurrence risk (Evidence: Strong 1).
  • Consider MRI for Definitive Diagnosis: Essential for accurate staging and planning of surgical intervention (Evidence: Strong 1).
  • Radiation Therapy for Incomplete Resection: May be considered in cases where complete resection is not feasible, though evidence is moderate (Evidence: Moderate 1).

    • References

    1 . You're the Flight Surgeon. Aerospace medicine and human performance 2017. link

    Original source

    1. [1]
      You're the Flight Surgeon. Aerospace medicine and human performance (2017)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG